Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
The U.S. Food and Drug Administration recently revised its warning information for a group of prostate drugs, including GlaxoSmithKline PLC’s Avodart and Merck & Co.’s Proscar, over concerns they may increase the risk of a more serious form of prostate cancer. The warning, which links use of the drugs to a greater risk of developing [...]
Medications that are used to treat diseases that affect a relatively small number of people and subsequently generate limited revenue for manufacturers are known as orphan drugs. The government has been offering tax benefits, research grants and market rights to pharmaceutical companies as incentives to develop these orphan drugs, in accordance with the Orphan Drug [...]
France’s drug authority announced on Thursday that it will suspend the use of two diabetes drugs, Actos and Competact, over concerns regarding cancer risks. The decision to issue the order for drug suspension came after the results of an official study conducted by the French Public Health Insurance Office revealed that the treatments were found [...]
Health Canada is currently reviewing the safety of Bayer Pharmaceutical’s birth control pills, Yaz and Yasmin, in an effort to determine if women who use these drugs are at an increased risk of developing life-threatening blood clots over women using different brands of birth control. The review was prompted by two new studies recently published [...]
The U.S. Food and Drug Administration issued a warning to generic drug maker, Impax Laboratories, Inc., regarding manufacturing practices in its Hayward, California pant. During a review conducted between Dec 13 and Jan 21, FDA inspectors identified problems with Impax’s sampling and testing procedures, as well as the process by which the company determines which [...]
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals unit was recently ordered by a South Carolina judge to pay more than $327 million in penalties relating to deceptive marketing practices for its drug, Risperdal. According to the 17-page ruling from Judge Roger Couch in Spartanburg, S.C., J&J’s executives “allowed the profit-at-all-costs mentality to cloud” their judgment regarding the [...]
According to an unsettling report released by the Office of the Inspector General for the Department of Health and Human Services, elderly residents in nursing homes are often prescribed antipsychotic drugs in a manner that violates government standards. This news is especially alarming for patients with dementia, as they are unable to advocate on their [...]
Following reports from two new studies claiming that birth control pills containing the progestin hormone, drospirenone, are more likely to pose a higher-than-expected risk of serious blood clots, the U.S. Food and Drug Administration issued a safety review of all drospirenone-containing birth control products. The expressed concern over drospirenone, which can be found specifically in [...]
Abbott Laboratories is currently the target of a product liability lawsuit, which was filed in May by Jamie Bixby in the U.S. District Court for the Northern District of Illinois. In the suit, Bixby alleges that her use of Abbott’s blockbuster drug, Humira, caused her to develop optic nerve damage and permanent vision problems. Humira [...]
